Baikang Bio

About:

Baikang Bio is an in vitro diagnostic and upstream core raw material developer of biological drugs.

Website: https://www.bioantibody.com.cn

Twitter/X: bioantibody

Top Investors: Fang Fund Partners, Bondshine Capital, Guoqian Venture Capital

Description:

Baikang Bio is a tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones, and other categories, from raw materials to finished goods. They are dedicated to innovation and providing their customers with solutions. They could contribute to human ecology and health.